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ABSTRACT

Does glutamine supplementation contribute to the incidence of diarrhea in ventilator
dependent patients?

by

Justin Johnson
Utah State University , 2007

In this project we investigated the incidence of diarrhea and its possible causes in
ventilator dependent patients in the intensive care unit (ICU) at McKay-Dee Hospital.
Chronic diarrhea has been a long time problem in the ICU, but the etiology has never
been fully explored. High dose antibiotic therapy has been thought to be a potential risk
factor . Another proposed risk has been the use of glutamine, a conditionally essential
amino acid contained in some enteral products. Glutamine is commonly used in feeding
critically ill patients because of its immune enhancing properties.
Currently, we have not established a correlation between the use of glutamine and
the incidence of diarrhea. Data obtained in this study, however, suggests that a correlation
exists with high-dose antibiotic therapy.
Future application of this research could lead to standard protocols in treatment of
diarrhea in the ICU. Such protocols might include all patients administered high dose
antibiotic therapy be given a probiotic supplement to prevent diarrhea. Also, if further
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evidence is found between glutamine supplementation and increased risk of diarrhea,
discontinuing or reducing supplementation could be considered an alternative measure.
(22 pages)
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INTRODUCTION

This was a retrospective chart review conducted at McKay-Dee Hospital in Ogden, Utah
during the period of January 2006 to December 2006 to determine risk factors for diarrhea. The
intent of this study was to verify if glutamine supplementation is associated with diarrhea in
ventilator dependent patients in the intensive care unit.
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REVIEW OF LITERATURE

Diarrhea in the Intensive Care Unit
It has been estimated that about one-third of patients admitted to the intensive care unit

(ICU) develop diarrhea during their hospitalization. The most common factors that have been
attributed to diarrhea include the use of antibiotic therapy, enteral feedings, and clostridium

difficile infection ( 1). Smith et al. (2) found that 63% of critically ill adult patients who required
mechanical ventilation experienced diarrhea associated with enteral nutrition (2). It was
concluded this was from improper administration of enteral products. Higher osmolarity and
infusion rates of enteral products contributed to an increased incidence and longer duration of
diarrhea (2). It has been estimated that 5% of reported diarrhea in ICU patients is attributed to
mechanical ventilation (3).
Diarrhea can lead to further complications such as volume depletion and wound
infection, which can considerably increase medical cost. Wu et al. (3) demonstrated that the
average length of stay in the ICU with complications of diarrhea was 8 days (3). The estimated
average cost per day ofICU care for the hospital is 6,000-7,000 dollars. In comparison, the
length of stay was only 4 days for those without complications of diarrhea (3). This supports the
rational that preventing diarrhea will decrease medical costs and ultimately provide optimal
health care for the patient.

Antibiotic Associated Diarrhea
Antibiotic associated diarrhea occurs in up to 25% of patients receiving antibiotics. Diarrhea
related to antibiotic use can occur after a single dose or may persist as long as 6 weeks after
discontinuing antibiotic therapy. The most commonly diagnosed and potentially severe form of
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antibiotic associated diarrhea is caused by Clostridium difficile , accounting for 15% to 25% of
antibiotic associated diarrhea. The human digestive tract is host to a vast of microbes and
harbors more than 500 identified species. Some of these bacteria are essential for health. To
prevent bacterial invasion, the mucosa of the gastrointestinal tract functions as a barrier to
numerous pathogens (4 ). Antibiotics alter the normal fecal flora, which predisposes the gut to
colonization by potentially pathogenic microbes, such as Clostridium difficile (5).
One method to treat antibiotic associated diarrhea and Clostridium difficile infection is
use of probiotics. Probiotics are live microbial food supplements or components of bacteria that
affect the host by improving microbial balance, and have been used as a way of restoring
beneficial intestinal microbes. The possible advantages of probiotics as therapeutic agents are
that they can lower the dependence on antibiotic use, decrease antibiotic associated diarrhea, are
relatively inexpensive , and are generally considered safe and well tolerated (5).
Currently , there are numerous forms of probiotics used in diarrhea prevention. One
particular probiotic that has been researched extensively is Saccharomyces boulardii . There is
evidence to support the use of Saccharomyces boulardii in the prevention of antibiotic associated
diarrhea at a dose of 1 gram daily in hospitalized adults. Surawicz et al. (6) treated 180
hospitalized patients , who were administered antibiotics , with 1 gram of Saccharomyces
boulardii daily or were administered a placebo (6). The patients continued treatment for 2 weeks
after the last antibiotic dose was given. Of the 180 patients , 21.8% of placebo treated patients
developed diarrhea, compared with 9.5% of patients treated with Saccharomyces boulardii (6).
There is no support for prophylactic probiotic treatment to prevent an initial infection of
Clostridium difficile, but Saccharomyces boulardii can be used to decrease its recurrences (4).
Future application ofthis research could lead to standard protocols in treatment of diarrhea in the

9

ICU. Such protocols might include all patients administered high dose antibiotic therapy be
given a probiotic supplement to prevent antibiotic-associated diarrhea.
Glutamine

Infection often occurs among critically ill patients. Infection contributes to increased
morbidity, mortality, and healthcare costs. Several therapies that may reverse
immunosuppression have been identified. One such therapy is glutamine supplementation and is
often added to enteral and parenteral products (7).
Over the past 20 years, glutamine has been reported to help maintain acid-base balance,
act as a primary fuel source for rapidly dividing cells, preserve integrity of gastrointestinal
mucosa, act as a substrate for purines and pyrimidines bases, synthesize glutathione and arginine,
and function as a key substrate for gluconeogensis (8).
Human studies have shown that glutamine supplementation can help decrease
infection, gram-negative bacteremia, nitrogen losses, and ventilator days, resulting in a decrease
in hospital length of stay and total healthcare cost (9). In a randomized, controlled clinical trial
in ICU patients, of which 71% were septic, glutamine supplementation resulted in a 24%
decrease in mortality (10). The positive effect of glutamine on morbidity related to infection was
also validated by a meta-analysis comparing the use of glutamine supplementation in surgical
and critically ill patients. There were 14 randomized trails included in this study that evaluated
the effect of glutamine versus standard care on clinical outcomes (11). The results showed a
reduced length of hospital days (on average a decrease of 2.6 days). In surgical patients
glutamine supplementation was associated with few infectious complications but no effect on
mortality was found. In critically ill patients glutamine supplementation was associated with a
reduction in infectious complications and improved morality rate (11).
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Glutamine is the most abundant amino acid in the body. It comprises 60% of the total
free amino acid pool. Much of the nitrogen transport from the skeletal to the visceral tissues is
via glutamine (8). Under normal physiologic conditions, glutamine is synthesized from
glutamate and glutamic acid by glutamate-ammonia ligase and is therefore considered
nonessential. However, it has been suggested that glutamine may become a conditionally
essential amino acid for patients in a catabolic state (11).
During periods of increased metabolic stress, glutamine is released freely from skeletal
muscle and intracellular glutamine concentrations fall by more than 50% (11). As a result,
during periods of catabolism glutamine synthesis cannot meet physiologic needs. Dietary
protein via oral or enteral routes provides only maintenance levels of glutamine. Furst et al. (12)
stated that during periods of stress, 15 to 35 grams of supplemented glutamine may be needed to
preserve muscle glutamine stores, maintain gut integrity, provide fuel for cells with rapid
turnover, and improve overall nitrogen balance (12).
The mechanism that explains the role of glutamines benefit during critical illness is
related to its interaction with arginine. One theory suggests that glutamine increases arginine
synthesis in the kidneys. Arginine aids in wound healing and is the precursor to nitric oxide.
Nitric oxide regulates blood flow through vital organs and is particularly critical during stress.
Thus, glutamine may be important in regulating blood flow by serving as a precursor to arginine
(13).

Recent evidence suggests that glutamine can induce heat shock proteins. Heat shock
proteins are a class of cellular chaperone proteins that support appropriate protein folding during
ribosomal translation. These proteins prevent poorly folded intracellular proteins.
Supplementation with glutamine increases production of heat shock proteins, enhancing cellular
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ability to protect against stress (8, 9). It has been found that individuals deficient in glutamine
manifest changes in gut morphology including increased membrane permeability resulting in
bacterial translocation, malabsorption, and diarrhea.
Dosing parameters for oral and enteral glutamine have varied widely over the years.
Current research has generally used 0.5 grams of glutamine per kilogram of actual body weight.
This level is thought to be sufficient to provide for the increase in glutamine required during
metabolic stress. Doses lower than 0.285 grams per kilogram of actual body weight has been
found to convey no benefit over standard feedings. It is also recommended that glutamine
dosing should be divided throughout the day to increase contact with enterocytes (8).

Glutamine Supplementation and Diarrhea
Recently, glutamine supplementation has been investigated to determine its relationship
to the incidence of diarrhea in the ICU. However, prior studies have not established a consistent
association between incidence of diarrhea and glutamine supplementation. One reason for this is
the very limited amount of research conducted in this area. In fact, there is no research published
to date that specifically has focused on this relationship. Until more research is gathered, debate
will continue on the association between glutamine supplementation and diarrhea. Some studies
have been conducted to determine the efficacy and safety of glutamine supplementation. It has
been reported that no adverse effects of glutamine have been observed when administered doses
of 50-60 grams of glutamine per day (14). However, there is evidence that protein intake,
greater than 200 grams per day, might be toxic. Furthermore, a consumption of more than about
40% of daily energy intake from protein sources can result in nausea and diarrhea (14). Because
glutamine is metabolized to glutamate and ammonia, both of which have known neurological
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effects, psychological and behavioral status should be monitored while on high doses of
glutamine (14).
It is of interest that dosing parameters for oral and enteral glutamine have varied widely

over the years. Current research has generally used 0.5 grams of glutamine per kilogram of
actual body weight. This level is thought to be sufficient to provide for the increase in glutamine
required during metabolic stress. Doses lower than 0.285 grams per kilogram of actual body
weight has been found to convey no benefit over standard feedings. It is also recommended that
glutamine dosing should be divided throughout the day to increase contact with enterocytes (8).
Glutamine supplementation enhances sodium and water reabsorption, and therefore
contributes to a decrease in diarrhea symptoms. It has been reported that patients with
inflammatory bowel disease experience decreased gastrointestinal symptoms and improved
quality of life when glutamine supplementation is given long-term (8). Bushen et al. (15)
conducted a study to determine the effects of glutamine therapy on diarrhea incidence in patients
with acquired immune deficiency syndrome (AIDS) (15). Subjects that received a high-dose of
glutamine had improved gastrointestinal symptoms. As a result, it was concluded that glutamine
was effective in decreasing diarrhea in patients with AIDS undergoing antiretroviral drug
treatment (15). In addition, Byrne et al. (16) found that 6 adult patients with short-bowl
syndrome that were given a combination of growth hormone, oral or intravenous glutamine, and
a high-fiber diet, had increased water, nitrogen, sodium and energy absorption and decreased
stool weights compared to baseline (16).
The proposed mechanism of the role of glutamine supplementation in diminishing
symptoms of diarrhea could be explained by the effect glutamine has on increasing plasma
concentrations of taurine. Taurine is an intracellular osmolyte that can regulate cell volume and
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therefore has a major influence on fluid homeostasis. It is plausible that glutamine may reduce
symptoms of diarrhea due to its impact on taurine availability (13 ).
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RESEARCH OBJECTIVE

The objective of this study was to establish a relationship between glutarnine
supplementation and diarrhea in ventilator dependent patients in the intensive care unit.
Therefore, the hypothesis that was tested is that glutarnine supplementation does not increase risk
for diarrhea in ventilator dependent patients in the intensive care unit.
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MATERIALS AND METHODS

Data Collection
This study was a retrospective chart review conducted at McKay-Dee Hospital in Ogden,
Utah from January 2006 to December 2006 to determine risk factors for diarrhea. All study
participants (n=l26) were admitted to the intensive care unit and placed on mechanical ventilator
assistance. This specific population was selected due to their known immunocompromised status
and the increased likelihood of being administered glutamine as a result (17). There were three
participants that were excluded from the study because they had a colostomy.
Potential variables assessed in this study were collected from the medical charting system
used at McKay-Dee Hospital. Potential variables included, but were not limited to stool output,
rectal tube use, glutamine supplementation, Beneprotein® supplementation, antibiotic therapy,
use of bowel stimulants, colonic lavage therapy, and blood detected in stools. Based upon this
information, independent variables were identified that could potentially affect the occurrence of
diarrhea. Specific variables selected for analysis were glutamine supplementation, Beneprotein®
supplementation, and antibiotic therapy.
Statistical Analyses
Contingency tables were calculated and chi-square analysis was used to compare the
expected contingency table to the observed contingency table. Logistic regression analysis and
modeling techniques were used to determine the associations between glutamine
supplementation and incidence of diarrhea. Initially odds ratios were used to evaluate the
incidence of diarrhea. The Breslow-Day test was used to assess the homogeneity of the odds
ratios.
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The dependent variable in the models was average stool output which had two values,
diarrhea (average stool output of 2 stools or more per day)=l and no diarrhea (average stool
output less 2 stools per day)= 0. The dependent variable was binary (0 or 1). The independent
variables were discrete in nature instead of continuous.
Because of the discrete nature of the data, the data was logit transformed and logistic
regression analysis was used. The logistic regression model used in this study was:
Ln{Y=[Prob(diarrhea=l)]/[Prob(no

diarrhea=0)]}=B0+Bl *Xl +B2*X2+ ..... +Bx*Xn

The X's were the independent variables. The B's were the logistic regression coefficients.
Their estimates were represented by b's. The B's represent the original unknown parameter ,
while b was its estimate.
The left-hand side of this relationship is known as the logit transformation of a
probability. It is also called the log-odds ratio. The odds ratio gives the linear relationship
between the dependent variable and the independent variable.
All statistical analyses were conducted with SAS statistical software program (SAS
System Version 8.02).
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RESULTS

Table 1.
Total days
of antibiotic
therapy
0-15
16-30
31-45
> 46
Total

Less than 10 days of
glutamine use
Average of Average of2
less than 2
or more
stools/day
stools/day
25
5
7
9
5
1
1
3
40
16

10 or more days of
glutamine use
Average of Average of2
less than 2
or more
stools/day
stools/day
4
2
11
2
7
1
5
3
27
8

Total

36
29
14
12
91

Table 1 depicts if stool output depends on glutamine use and if this effect is modified by
antibiotic therapy. The marginal odds-ratio is 0.74 , which may indicate that glutamine is
inversely related to stool output.

Table 2.
Total days of antibiotic
therapy
0-15
16-30
31-45
> 46

Stratum-wide
odds-ratio
2.5
0.23
0.71
0.2

Yet, it appears that antibiotic therapy could be a potential confounding factor because
antibiotic therapy appears to affect the average stool output per day according to table 2.
However, there are small cell counts in the last 2 strata , which may have impacted the results.
There appears to be an association between antibiotic therapy and glutamine use, but
there appears to be no association between glutamine use and stool output.
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The Breslow-Day test assessed the homogeneity of the odd-ratios and the result was B 2 =
4.1781 , with a p-value of 0.2449. Therefore , there is no significant difference among odds-ratios
and the small cell counts in the last 2 strata are most likely the cause of the association and the
differences are due to chance
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DISCUSSION

Although further research is warranted, this study supports the hypothesis that glutamine
use does not increase risk for diarrhea.
These findings also support previous research that antibiotic therapy may be related to
frequency of stool output. As reported by Katz, antibiotic associated diarrhea occurs in up to
25% of patients receiving antibiotics (5).
Of greater importance to future research is the fact that this study showed that glutamine
use does not appear to increase risk for diarrhea and in fact, may appear to have a protective
effect. The proposed mechanism of the role of glutamine supplementation in diminishing
symptoms of diarrhea could be explained by the effect glutamine has on increasing plasma
concentrations of taurine. Taurine is an intracellular osmolyte that can regulate cell volume and
therefore has a major influence on fluid homeostasis. It is plausible that glutamine may reduce
symptoms of diarrhea due to its impact on taurine availability (13 ).
Our findings are in accordance with that of prior research in that there have been no
reported adverse side effects of glutamine supplementation (14). However , this was a correlation
study and cannot be used to unequivocally state that glutamine use is not related to diarrhea and
may exhibit a protective effect against stool output. Furthermore, there were potential variables
such as tube feed rate, sorbitol use, and recent gastrointestinal surgeries that may impact stool
output that were not obtained. One limitation of this study is the small sample size. Statistical
significance may have been achieved with a larger sample size. Consequently, continuation of
this study should be considered to possibly obtain a stronger association.
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SUMMARY

Recently, glutamine supplementation has been investigated to determine its relationship
to the incidence of diarrhea in the ICU. However, prior studies have not established a consistent
association between incidence of diarrhea and glutamine supplementation. The focus of this
study was to perform a statistical analysis on various data collected form the medical charting
system at McKay-Dee Hospital in ventilator dependent patients to determine whether there was
an association between glutamine supplementation and diarrhea. Although further research is
warranted, this study supports the hypothesis that glutamine use does not increase risk for
diarrhea.
Findings from this study support previous research that antibiotic therapy may be related
to frequency of stool output. There are many benefits of glutamine supplementation in critically
ill patients. One in particular is that glutamine may exhibit a protective effect against diarrhea.
Wu et al. (4) demonstrated that the average length of stay in the ICU with complications of
diarrhea was 8 days (4). In comparison, the length of stay was only 4 days for those without
complications of diarrhea (4 ). This supports the rational that preventing diarrhea will decrease
medical costs and ultimately provide optimal health care for the patient. The results and
conclusions derived from the data may eventually lead to standard protocols in treatment of
diarrhea in the ICU.
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